Objective-To be able to measure disability objectively in rheumatoid arthritis complicated by cervical myelopathy. Methods-The responses to the Stanford health assessment questionnaire disability index were recorded from 250 consecutive patients (group 1) referred to our unit for spinal surgery. Using principal components analysis the questionnaire was reduced from 20 questions to 10 questions. In the second part of the study, the results of the questionnaire for those patients undergoing surgery from the original group of 250 patients were analysed with respect to outcome.
Abstract
Objective-To be able to measure disability objectively in rheumatoid arthritis complicated by cervical myelopathy. Methods-The responses to the Stanford health assessment questionnaire disability index were recorded from 250 consecutive patients (group 1) referred to our unit for spinal surgery. Using principal components analysis the questionnaire was reduced from 20 questions to 10 questions. In the second part of the study, the results of the questionnaire for those patients undergoing surgery from the original group of 250 patients were analysed with respect to outcome.
Results-The reduction in the number of questions resulted in no significant loss of information, reliability (internal consistency Cronbach's a = 0.968) or sensitivity. The new scale, the myelopathy disability index, measures only one dimension (Eigen value 6.97) and may be more finely tuned to the measurement of disability in these myelopathic patients. When administered to the 194 patients undergoing cervical spine (group 2) surgery the myelopathy disability index was an accurate predictor of neurological and functional outcome, as well as survival following surgery (P < 0.0001). Conclusions-The myelopathy disability index provides a much needed objective and reliable means of assessing disability in patients with rheumatoid involvement ofthe cervical spine and also in predicting outcome following surgical intervention. It also provides information for both the patient and surgeon alike, on what to realistically expect from surgery. Its adoption should facilitate comparisons between different forms of surgical intervention.
(Ann Rheum Dis 1996;55: [901] [902] [903] [904] [905] [906] In determining the severity of any disease process, the effects of surgical intervention, or the factors that influence prognosis and survival, it is essential to have objective and reproducible means of measuring the patient's disability before and after surgery. Pain can be reliably assessed by means Interest in the measurement of physical function of chronically disabled patients with arthritis has increased significantly over the last 10 years. There is unfortunately no gold standard. Of the instruments developed, the physical disability dimension of the Stanford health assessment questionnaire (HAQ)7 has been shown to have the necessary qualities to evaluate functional disability and has been validated in many settings, with cross cultural reliability being demonstrated in several studies.>'0 Its use has largely centred on quantifying short term drug effects," but it also has been used to identify risk factors for disease progression.2 13 More recently it has also been modified for use with ankylosing spondylitis, systemic lupus erythematosus, diabetes, HIV, and orthopaedic evaluation following hip arthroplasty.'s'7 It has not previously been validated specifically for cervical myelopathy secondary to the rheumatoid process. The purpose of this study has been to explore its use in this specific context, but also to see if refinements can be made to its structure by reducing the number of questions. This might help to reduce the level of noise or interference from extraneous questions and also make it more user friendly. An information The normal distribution curve is superimposed. scores in a similar way to the pretreatment Ranawat class (fig 2) . of sensitivity or responsiveness. The corresponding values for the Steinbrocker grades (SRM -0.32; ERM -0.35) and Ranawat classes (SRM -43; ERM -0.42) were essentially similar. These gradings, however, are only 4 point scales and while they may have similar sensitivity statistics to the summated HAQ and MDI it should not be forgotten that the changes in individual question responses before and after surgery are often of interest to the clinician.
SURVIVAL ANALYSIS
Kaplan-Meier survival curves were created to examine survival following surgery (fig 3) . A Cox regression model was then constructed to examine the predictive power of the various grading systems in predicting survival following surgery. Both the HAQ (P < 0.0002), and the myelopathy disability index (P < 0.0001), are significant predictors of survival, the latter predicting slightly better, as shown by a higher ratio of coefficient to standard error and hence lower P value and the higher pseudo Survival time, months Figure 3 Kaplan-Meier survival curves for the operative series ofpatients with patients described according to their preoperative status using the Stanford health activity questionnaire, the myelopathy disability index, the Ranawat classification, and the American College ofRheumatology (Steinbrocker) grades. All predict survival at P < 0. 0001 except for the Stanford health assessment questionnaire (P = 0. 0002). The scores for the Stanford health assessment and the myelopathy disability index have been stratified into three groups for graphical representation. HAQ-I = <1;HAQ-II = 21<2; HAQ-III = .2. The corresponding groupings for the MDI are spaced at <33%; 33% < 67%; and .67%. the degree of vertical translocation of the odontoid peg through the foramen magnum (r = -0.29, P = 0.0002).2o All correlated significantly, and in the appropriate direction, with the new myelopathy index, albeit to varying degrees.
Discussion
The advantages of modifying an existing questionnaire is that the questions have already gone through a process of evolution and rigorous assessment.'6 Indeed it is on this very basis that Fries and his colleagues set about creating the Stanford health assessment questionnaire7 25 with potential component questions being selected from a variety of sources including the Bartel index and the index of independence in activities of daily living.2627 Areas of redundancy, imprecision, and ambiguity were identified and the questionnaire appropriately modified. By adopting their questions we have obviated the need for formal retesting of these questions which have already undergone tests of replicability or reliability, objectivity, and validity.7 1 25 The use of a self administered questionnaire has advantages over an interview as a means of assessing outcome.'6 It is less expensive to administer and does not depend on the skill of a particular interviewer or require interobserver validation.
The limitations of a neurological examination in the determination of mild muscle weakness have been highlighted in a nonarthritic patients with a kappa coefficient of only 0.22 when the examiner was unaware of the clinical history.5 Indeed the major difficulties presented by patients with rheumatoid arthritis with their painful deforming arthritis, which so limits a conventional neurological examination" was one of the major forces in the development of our myelopathy disability index. We would be naive to believe that our statistical manoeuvres could completely separate functional disability as a direct consequence of cervical cord compression from the general effects of the rheumatoid disease process, but we feel that our disease specific instrument will discriminate between myelopathic patients in terms of their physical disability.
One We have also demonstrated that this scale is a powerful predictor of outcome following surgery, both in terms of neurological and functional outcome but perhaps more importantly of survival following surgery. It has clinical relevance in that it has significant correlations with those radiological variables of interest (posterior atlantodens interval, cord diameter, cord area, and the degree of vertical translocation)."" An area of future research would seek to identify those patients, using this new myelopathy score, with neurological deterioration which hitherto has been masked by their painful deforming arthritis. A deterioration in function, independent of a flare up in their rheumatoid process, would be an indication for the clinician to reassess the patient both clinically and radiologically (x rays, CT scan, and MRI) with a particularly critical eye. We have found this, in conjunction with a pain visual analogue scale for occipitocervical pain,' to be a useful adjunct to our standard clinical evaluation in detecting late failures in our surgical series. This of course measures a different dimension and could not be incorporated directly into our disability index. 25 Surgery to the rheumatoid cervical spine is not a minority interest, it is a major health problem, with a recent cross sectional population study from This new myelopathy disability index scale would have widespread applicability and its ease of administration would not confine it to academic centres alone. The lack of a common language of reliable and well validated instruments has produced a situation in which it has become difficult to assess the results of treatment objectively, or document the effectiveness or indeed ineffectiveness, of surgical intervention.32 The whole area of outcome research in cervical spine surgery has been found to be wanting, with little emphasis on patient-perceived outcomes.'2 This new disability index will hopefully remedy this shortcoming for rheumatoid cervical myelopathy, but future uses may also include extrapolating the use of this myelopathy score to other causes of cervical myelopathy such as cervical spondylosis, spinal cord trauma, or tumour surgery. Its adoption in these areas will no doubt complement the existing methods of assessment.""
CONCLUSION
In conclusion, we have refined the Stanford HAQ for use in rheumatoid cervical myelopathy. We believe this to be a superior instrument to the original HAQ for our specific purposes of measuring disability in the rheumatoid patient with cervical myelopathy. Combined with a pain visual analogue scale it provides a comprehensive assessment of the patient with rheumatoid involvement of the cervical spine. The myelopathy disability index has been shown in this study to convey useful prognostic information and has the potential to form the basis of future outcome studies comparing the results of surgery between different surgical groups and management options. 
